Psound Bytes Pro

Hear pulmonologist, Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates, and Deb Brown, Chief Mission Officer also with ALA, address the toxic impact of smoking on inflammatory diseases such as psoriasis. This episode includes a free smoking cessation program offer for patients. For disclosures and to claim credit, go to https://bit.ly/2QqzJeM.

Join us for our new Psound Bytes Journal Club series discussing noteworthy publications in psoriatic disease. In this first episode we discuss three recent trial results for therapeutics in the pipeline with dermatologists Dr. Mark Lebwohl, Professor and Chairman, Dept. of Dermatology, Icahn School of Medicine, Mt. Sinai Health System in New York, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR. For disclosures and to claim .5 CME credits go to cme.psoriasis.org. For publication links: https://bitly.31a6a7s

Hear preliminary data and how to participate in PsoProtect, an international registry for health care providers, from Dr. Catherine Smith, Professor of Dermatology and Therapeutics/Consultant Dermatologist, and Dr. Satveer Mahil, a Consultant Dermatologist, at St.. John's Institute of Dermatology, Kings College London. Help advance an understanding of how risk factors, immunomodulatory therapies and comorbidities affect COVID-19 outcomes in people with psoriasis and psoriatic arthritis, and how data results may impact clinical decisions.

Hear tips for maximizing psoriasis care from one of the country's leading experts in teledermatology, Dr. George Han, System Medical Director for Dermatology at Mount Sinai Health System and Chief of Teledermatology at Icahn School of Medicine at Mount Sinai. Listen as Dr. Han addresses access issues, system types and set-up, appointment challenges and reimbursement. To view disclosure information and claim credit go to https://www.eeds.com/em/1400. This program is supported by charitable contributions from Amgen, Janssen Pharmaceutical Companies of Johnson & Johnson, and Novartis.

Hear George Han, M.D. of the Icahn School of Medicine at Mt. Sinai, and Mark Kaufmann, M.D., President-Elect at the American Academy of Dermatology, discuss the new normal for dermatologists and learn about ILUMYA™ (tildrakizumab-asmn), a treatment for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For Important Safety Information: https://bit.ly/2We7fIS. For Full Prescribing Information: https://bit.ly/2xLEfil.

Discover why it's important to have guidelines addressing the use of systemic nonbiologic therapies and why oral agents still play a role now and in the future treatment of psoriatic disease from one of the country's leading prescribers, dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee. To view disclosure information and claim credit go to https://www.eeds.com/em/1377. This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.

Scalp psoriasis is considered one of the more difficult to treat manifestations of psoriasis. Hear leading dermatologist Dr. Jennifer Soung, Director of Clinical Research at Southern California Dermatology in Santa Ana, CA, share her tips about managing and treating mild-to-moderate and severe scalp psoriasis. To view disclosure information and claim credit, go to https://www.eeds.com/em/1307. This program is supported by unrestricted educational grants from AbbVie, Lilly and Ortho Dermatologics.

Could inclusion of measuring psoriatic arthritis symptoms in psoriasis clinical trials be a step towards reducing the gap in diagnosis of PsA? That's a question asked of renowned rheumatologist and NPF Board Member, Dr. Elaine Husni, Vice Chair of the Department of Rheumatic and Immunologic Diseases and Director of the Arthritis and Musculoskeletal Center at the Cleveland Clinic. Hear this discussion of the JAAD article "Measuring Psoriatic Arthritis Symptoms: A Core Domain in Psoriasis Clinical Trials". To view disclosure information and claim credit, go to https://www.eeds.com/em/1275 . Article link: https://pubmed.ncbi.nlm.nih.gov/31163240/ .

From diagnosis to therapy options nail psoriasis can be a challenge to treat. Listen as leading dermatologist and NPF Medical Board Member, Dr. April Armstrong, Director of the Psoriasis Program, Dept. of Dermatology at Keck School of Medicine, USC, addresses the challenges and offers tips to help manage nail psoriasis. For disclosure information and claim credit go to https://www.eeds.com/em/1271. For more information read the JPPA article "Nail Psoriasis: A Review of Treatment Options" https://journals.sagepub.com/doi/pdf/10.1177/247553031016.00405. This activity is supported by grant funding from AbbVie, Amgen and Lilly.

Hear special guest Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates discuss what COVID-19 means for your patients; risks, symptoms, possible treatments and overall impact moving forward. Includes a discussion of patient resources available through the American Lung Association from Chief Mission Officer, Ms. Deb Brown. For a helpful patient fact sheet with tips for using telehealth contact the National Psoriasis Foundation's Patient Navigation Center at [email protected]. To view disclosure information and claim credit, go to https://www.eeds.com/em/1170.